Palantir’s CEO Manifesto Rattles Markets Even as $300 Million USDA Deal Lands

Alex Karp has never been one for quiet diplomacy. The Palantir chief executive’s mid-April manifesto, “The Technological Republic,” calls for aggressive AI militarization and a reinstatement of the US draft — a polemic that critics have branded techno-fascist. The timing could hardly be worse for shareholders. Even as the data-analytics firm locked down a $300 million framework agreement with the US Department of Agriculture, the stock has been sliding. By Friday’s close in Europe, shares had settled at €119.94, a near-11% decline over the past 30 days.

The disconnect between corporate wins and market performance is stark. The USDA contract, announced just days before the manifesto’s release, is meant to modernize farm management systems — a significant endorsement of Palantir’s government-facing capabilities. Yet the stock opened roughly 7% lower on Thursday at $141.57, erasing any post-deal optimism. Analysts point to a broader rotation out of technology names, compounded by heavy insider selling. Over the past three months, executives have offloaded more than one million shares, with CEO Karp himself selling over 490,000 — though the company notes those disposals were tied to tax obligations under a pre-arranged trading plan.

Institutional Crosscurrents

The shareholder base is anything but unified. The Swiss National Bank, which holds a position worth well over $1 billion, is fending off demands from ESG activists in Minneapolis who want it to divest on human-rights grounds, citing Palantir’s role in US immigration enforcement. The SNB does not comment on individual holdings, but its silence has done little to quiet the noise. Meanwhile, other large investors have trimmed their stakes, and the technical picture has deteriorated. The stock now trades more than a third below its 52-week high of roughly €180, and has been languishing beneath its 200-day moving average — a bearish signal reinforced by a “death cross” formation in February.

Should investors sell immediately? Or is it worth buying Palantir?

Analysts Hold the Line

Wall Street’s sell-side, however, remains broadly constructive. The DZ Bank initiated coverage with a “Buy” rating and a $175 price target. Rosenblatt reaffirmed its “Buy” stance with a $200 target, citing sustained momentum in Palantir’s AI business. Wedbush is the most bullish, sticking with a $230 target. The consensus average sits at around $196 — implying roughly 60% upside from current levels, if the market ever decides to listen.

Earnings as the Next Catalyst

All eyes now turn to May 4, when Palantir reports first-quarter results after the US market close. The bar is high. Analysts project revenue of roughly $1.54 billion, representing 74% year-over-year growth, with earnings per share of $0.27. That would follow a Q4 2025 performance where revenue surged 70% to $1.41 billion and US commercial revenue jumped 137%.

The real focus, though, will be on management’s full-year guidance. Palantir currently targets 2026 revenue between $7.18 billion and $7.20 billion, a 61% increase. An upward revision could provide the spark the stock desperately needs. Whether the numbers are strong enough to bridge the chasm between analyst optimism and market skepticism — and to drown out the political noise from the corner office — will be decided in just over two weeks.